Polymorphism of the 4-Hydroxylation of Debrisoquine in the San Bushmen of Southern Africa
- 1 May 1988
- journal article
- research article
- Published by SAGE Publications in Human Toxicology
- Vol. 7 (3) , 273-276
- https://doi.org/10.1177/096032718800700308
Abstract
1 The metabolic oxidation of debrisoquine has been studied in a group of 96 San Bushmen.Keywords
This publication has 12 references indexed in Scilit:
- Metoprolol and debrisoquin metabolism in nigerians: Lack of evidence for polymorphic oxidationClinical Pharmacology & Therapeutics, 1986
- A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquinClinical Pharmacology & Therapeutics, 1985
- Genetically determined oxidation capacity and the disposition of debrisoquine.British Journal of Clinical Pharmacology, 1983
- HYDROXYLATION OF DEBRISOQUINE IN PATIENTS WITH LACTICACIDOSIS AFTER PHENFORMINThe Lancet, 1981
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980
- A study of the debrisoquine hydroxylation polymorphism in a Nigerian populationXenobiotica, 1980
- Debrisoquin hydroxylation polymorphism among Ghanaians and CaucasiansClinical Pharmacology & Therapeutics, 1979
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977